Overview
Fund Size (AUM)
₹1401.60 Cr
as on 17 May 2026
CAGR
2.30%
1 Year
as on 30 Apr 2026
Expense Ratio
1.84 %
as on 30 Apr 2026
Fund Age
10 years 4 months
since 28 Dec 2015
Exit Load
0.25% of NAV
Within 30 days
₹31.74
as on 21 May 2026An open ended equity scheme investing in Pharma and Healthcare Services Sector.
The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of it’s net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved. The Scheme does not assure or guarantee any returns.
The fund manager builds the portfolio around the following parameters:
0.25% of NAV if redeemed/switched out before 30 days from the date of allotment.
₹ 100
Lumpsum
₹ 5,000
₹100
₹ 10 Lakhs
Worth of investments in last
This Fund
N.A.
0%
BSE HC TRI
N.A.
0%
Nifty 50 TRI
N.A.
0%
| Key Measures** | Fund | Benchmark |
|---|---|---|
| Standard Deviation | 17.06 | 16.65 |
| Sharpe Ratio | 0.95 | 1.13 |
| Portfolio Beta | 0.91 | NA |
| R Squared | 0.84 | NA |
| Treynor | 1.49 | NA |
| Jenson | -0.08 | NA |
| Current value of ₹10,000 invested | ||||||
|---|---|---|---|---|---|---|
| Annualized (%) | BSE HC TRIBenchmark(%) | Nifty 50 TRIAdditional Benchmark(%) | Scheme | BSE HC TRIBenchmark(%) | Nifty 50 TRIAdditional Benchmark(%) | |
Since Inception 28 Dec 2015 | 11.21% | 10.49% | 12.65% | ₹30,027 | ₹28,068 | ₹34,297 |
| Last 1 Year | 2.30% | 6.27% | -0.28% | ₹10,230 | ₹10,627 | ₹9,972 |
| Last 3 Years | 22.03% | 25.30% | 11.18% | ₹18,201 | ₹19,710 | ₹13,753 |
| Last 5 Years | 13.39% | 14.33% | 11.69% | ₹18,750 | ₹19,545 | ₹17,382 |
Managing since 16 Sept 2024
** Investors should understand that their principal will be at Very High risk
